Markus Vähä‐Koskela

Immunogenomic Landscape of Hematological Malignancies

Olli Dufva, Petri Pölönen, Oscar Brück et al. · Cancer Cell · 2020 · 199 citations · Full text

Medicine, Hematology, Immunology +14

Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis

Thi Lien-Anh Nguyên, Hesham Abdelbary, Meztli Arguello et al. · Proceedings of the National Academy of Sciences · 2008 · 181 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions

Jing Tang, Ziaurrehman Tanoli, Balaguru Ravikumar et al. · Cell chemical biology · 2017 · 171 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia

Heikki Kuusanmäki, Olli Dufva, Markus Vähä‐Koskela et al. · Blood · 2022 · 125 citations · Full text

Medicine, Oncology, Pharmacology +16

A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers

Jean‐Simon Diallo, Fabrice Le Bœuf, Frances W. Lai et al. · Molecular Therapy · 2010 · 101 citations · Full text

Life Sciences, Medicinal Chemistry, Oncology +17